SS
OACC

Steve Schonfeld’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Steve Schonfeld’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
144,677
+34,570
+31% +$368K 0.01% 1203
2026
Q1 		$1.17M Sell
110,107
-5,067
-4% -$53.9K 0.01% 1020
2025
Q4 		$1.22M Sell
115,174
-9,826
-8% -$104K 0.01% 1049
2025
Q3 		$1.31M Sell
125,000
-430,000
-77% -$4.49M 0.01% 1251
2025
Q2 		$5.8M Buy
555,000
+195,800
+55% +$2.03M 0.04% 524
2025
Q1 		$3.67M Buy
+359,200
New +$3.61M 0.02% 647

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Steve Schonfeld's OACC Position: Q2 2026 in Review

Steve Schonfeld increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 31% in Q2 2026, buying an estimated $368K and bringing the position to 144,677 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #1203.

Steve Schonfeld first reported a position in OACC in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.8M in Q2 2025. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Steve Schonfeld held 144,677 shares of Oaktree Acquisition Corp III Life Sciences worth $1.55M as of Q2 2026.
  • Steve Schonfeld bought 34,570 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $368K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1203 holding.
  • Steve Schonfeld first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Steve Schonfeld's Oaktree Acquisition Corp III Life Sciences position peaked at $5.8M in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.